Provided by Tiger Fintech (Singapore) Pte. Ltd.

Argenx SE

649.67
+9.771.53%
Post-market: 649.670.00000.00%19:55 EDT
Volume:318.15K
Turnover:207.00M
Market Cap:39.67B
PE:50.83
High:656.29
Open:656.29
Low:646.58
Close:639.90
Loading ...

Is Butterfly Network (BFLY) Stock Outpacing Its Medical Peers This Year?

Zacks
·
09 Dec 2024

Should You Increase Your Holdings in argenx SE (ARGX)?

Insider Monkey
·
09 Dec 2024

European Equities Traded in the US as American Depositary Receipts Slightly Higher in Wednesday Trading

MT Newswires Live
·
05 Dec 2024

Three Stocks Estimated To Be Undervalued In December 2024

Simply Wall St.
·
03 Dec 2024

Why Is Argenx SE (ARGX) Among the Best High Growth Healthcare Stocks to Invest In Now?

Insider Monkey
·
03 Dec 2024

argenx Se : Jefferies Raises Target Price to $707 From $689

THOMSON REUTERS
·
22 Nov 2024

Argenx price target raised to EUR 670 from EUR 650 at Barclays

TIPRANKS
·
22 Nov 2024

Oppenheimer Adjusts argenx SE ADR Price Target to $675 From $646, Maintains Outperform Rating

MT Newswires Live
·
22 Nov 2024

Argenx price target raised to $706 from $675 at Evercore ISI

TIPRANKS
·
21 Nov 2024

Oppenheimer Reaffirms Their Buy Rating on Argenx Se (ARGX)

TIPRANKS
·
21 Nov 2024

Positive Clinical Trial Results and Market Position Strengthen Buy Rating for Argenx SE

TIPRANKS
·
21 Nov 2024

argenx Price Target Maintained With a $617.00/Share by HC Wainwright & Co.

Dow Jones
·
21 Nov 2024

Argenx may have first targeted myositis treatment, says H.C. Wainwright

TIPRANKS
·
21 Nov 2024

Sector Update: Health Care Stocks Edge Higher Premarket Wednesday

MT Newswires Live
·
20 Nov 2024

Argenx Se (ARGX) Receives a Buy from Stifel Nicolaus

TIPRANKS
·
20 Nov 2024

Argenx to Continue Development of Autoimmune Disease Drug After Phase 2/3 Data

MT Newswires Live
·
20 Nov 2024

Argenx to continue development of efgartigimod subcutaneous

TIPRANKS
·
20 Nov 2024

Is argenx SE (ARGX) the Best Immunotherapy Stock to Buy Now?

Insider Monkey
·
18 Nov 2024

Argenx Se (ARGX) Gets a Buy from Truist Financial

TIPRANKS
·
18 Nov 2024

Morgan Stanley Raises Price Target on argenx to $675 From $580, Keeps Overweight Rating

MT Newswires Live
·
18 Nov 2024